SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-021226
Filing Date
2023-05-11
Accepted
2023-05-11 16:09:12
Documents
13
Period of Report
2023-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K grts-20230511.htm   iXBRL 8-K 58279
2 EX-99.1 grts-ex99_1.htm EX-99.1 262178
  Complete submission text file 0000950170-23-021226.txt   453568

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT grts-20230511_lab.xml EX-101.LAB 13350
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT grts-20230511_pre.xml EX-101.PRE 9840
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT grts-20230511.xsd EX-101.SCH 2469
7 EXTRACTED XBRL INSTANCE DOCUMENT grts-20230511_htm.xml XML 4709
Mailing Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608
Business Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608 (510) 871-6100
Gritstone bio, Inc. (Filer) CIK: 0001656634 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38663 | Film No.: 23911041
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences